Navigate Fool.com
Will GEVO beat
the market?


Community Rating: 3 Stars: Appealing

0.59 -0.01 (-1.13%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.60
Previous Close $0.59
Daily Range $0.57 - $0.61
52-Week Range $0.55 - $2.18
Market Cap $40.4M
P/E Ratio -0.49
Dividend (Yield) $0.00 (0.0%)
Volume 782,057
Average Daily Volume 320,810
Current FY EPS -$0.68

How do you think GEVO
will perform against the market?

Top GEVO Bull/Bear Pitches


TMFBlacknGold (< 20)
Submitted November 11, 2013

I can't officially write about Gevo due to its low market cap (disqualified from company-focused articles in TMF's conduct rules), but I still see it as a good, perhaps amazing, long term investment w … More

1 Replies Reply Report this Post

mkocolos (0)
Submitted September 8, 2012

Promising technology, but high production costs and legal issues may prevent them from achieving profitability in the near term

0 Replies Reply Report this Post

News & Commentary Rss Feed

Department of Defense Needs These Companies to Succeed

These industrial biotech innovators could get a big boost if this latest partnership works out.

A Solazyme Investor's Guide to 120,000 Tons of Renewable Oil

The next few quarters will be full of announcements about commercial facilities throughout industrial biotech. Will you know how to interpret them?

3 Terms Solazyme Investors Absolutely Must Know

Don't get lost in the jargon of industrial biotech. Here are three terms you need to know to be a successful investor in the nascent industry.

4 of the Best Stocks Offering Good Value

Snapshots of each company are provided as a starting point for further research.

Synthetic Biology Is the Solution to Chemical Explosions

A recent string of chemical plant explosions serves as a reminder that industrial biotech isn't just more sustainable than old processes, but potentially safer, too.

Did Solazyme Just Get Riskier?

Today’s news isn’t great, but let’s not panic about Solazyme.

3 Things That Could Slow Down Solazyme

A short list of headwinds facing investors or potential investors in Solazyme.

Investment Advice From Industrial Biotech Insiders

A Fool takes advantage of insiders taking advantage of recent share run-ups to preach the importance of patience.

Closing Bell for Wednesday on Wall Street: Markets Open Low, Sink on FOMC Statement

Closing Bell for Wednesday on Wall Street: Markets Open Low, Sink on FOMC Statement

See More GEVO News...


Basic Materials



GEVO INC (GEVO) Description

GEVO INC Website: http://www.gevo.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks